Urgent.News

What's breaking now, across thousands of outlets.

AI

Z.AI shares fall to 5-1/2-month low after $5 billion share, bond sale

Z.AI shares fall to 5-1/2-month low after $5 billion share, bond sale

Z.AI shares declined nearly 7% on Monday, reaching a five-and-a-half month low as the Chinese artificial-intelligence firm launched a $5 billion fundraising that involved a discounted share placement and convertible bond offering. The stock plummeted to HK$739, the lowest point since March 31, trailing the broader Hang Seng Index, which remained largely flat.

The company raised funds from a mix of $2 billion in new shares and $3 billion in convertible bonds, marking a stark contrast to its 2026 peak. The decline in share price reflects a broader retreat in investor confidence towards high-valued Chinese AI companies. The firm sold 21.97 million new Hong Kong shares at HK$714 apiece, a roughly 10% discount to its prior trading price of HK$793.

Additionally, it issued 20.14 billion yuan ($3 billion) of zero-coupon convertible bonds due in September 2027, priced at an initial conversion rate of HK$892.50, a 25% premium above the placement price. The discounted equity issuance is expected to exert downward pressure on the shares as it swells the number of outstanding shares, while the convertible bonds may lead to further dilution if converted into equity in the future.

However, the enhanced conversion price implies that any eventual conversion would only materialize if the stock recovers significantly from its current levels. This fundraising underscores the substantial capital demands facing AI developers as they scale up computing resources and refine sophisticated models. Roughly 60% of Z.AI's net proceeds will be allocated to research and development of next-generation models and its fully self-training system, while an additional 15% is designated for expansion.

The remaining funds will be deployed to refine the company's capital structure, bolster working capital, and finance other corporate activities. The additional capital endows Z.AI with a greater financial capacity to invest in computing infrastructure and AI development as it competes with Chinese rivals like DeepSeek, Moonshot AI, and MiniMax, as well as U.S. counterparts including OpenAI, Anthropic, and Google.

Z.AI had previously secured about $4 billion in a follow-on share sale in July, indicating that the latest financing round occurred just around two months later.

Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at investing.com →

More in AI

Beyond Detection: Coreline Soft Sees Lung Cancer Screening AI Evolving into a Digital Pathway

The global race in artificial intelligence for lung cancer screening is beginning to move beyond a familiar question: how accurately can an algorithm detect a pulmonary nodule?As screening programs…

  • Coreline Soft's AVIEW platform expands to nodule management and emphysema assessment.
  • AI integration challenges in Europe and Korea's national program.
  • Focus shifts to practical AI adoption beyond detection accuracy.

More from Monday 14 September →